search engine marketing

Master Hormones Management Institute.Master Hormones Management Institute.
  Login or Register
| Home  |  Downloads  |  Your Account  |  Forums  |
Modules
· Home
· BLOG
· Contact Us
· Downloads
· FAQ
· Forums
· Master Hormones Guide
· MH Price Catalog
· News for Palm
· Private Messages
· Recommend Us
· Search
· Stories Archive
· Surveys
· Top 10
· Topics
· Web Links
· Your Account
 
Login
Nickname

Password

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.
 
Price Catalog
· Main category
· Laboratory Screening Tests
 
Search


 
Who''s Online
There are currently, 94 guest(s) and 0 member(s) that are online.

You are Anonymous user. You can register for free by clicking here
 
Languages
Select Interface Language:

 
Users
Welcome, Guest
Nickname
Password
(Register)
Membership:
Latest: DrewTom61
New Today: 0
New Yesterday: 0
Overall: 2062

People Online:
Visitors: 94
Members: 0
Total: 94
 
masterhormones.com :: View topic - Clinical Trials Fingolimod VS Copaxone!
Forum Index
Welcome ( Log in | Register )

Profile | Forum FAQ | Search | Memberlist | Usergroups
Clinical Trials Fingolimod VS Copaxone!

 
Post new topic   Reply to topic    masterhormones.com Forum Index -> US Healthcare rules and regulations
View previous topic :: View next topic  
Author Message
vican51
Newbie
Newbie


Joined: Jul 09, 2006
Posts: 606
Location: Manassas, Virginia, USA

PostPosted: Wed Jun 07, 2017 7:46 am    Post subject: Clinical Trials Fingolimod VS Copaxone! Reply with quote

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
This study is to compare 2 doses (0.25 mg and 0.50 mg) of fingolimod to glatiramer acetate (20 mg) and to evaluate the efficacy of fingolimod 0.25 mg for the treatment of patients with relapsing-remitting MS (RRMS).

Study Start Date: August 2012

Estimated Completion Date: June 2023

Specialties: Internal Medicine: Clinical Pharmacology,Neurology Neurology: Demyelinating Disorders,Neuro/Psych pharmacology Family Medicine: Clinical Pharmacology,General Medicine Pharmacy: Drug Trials,Neuro/Psych pharmacology

Interventions

Drug: fingolimod
Drug: copaxone

Inclusion criteria

Written informed consent must be obtained before any assessment is performed
Male and female patients 18 to 65 years of age, inclusive.
Patients with RRMS, as defined by 2010 revised McDonald criteria.
Patients must be neurologically stable with no onset of relapse or any steroid use within 30 days of randomization
Patients with at least 1 documented relapse during the previous year or 2 documented relapses during the previous 2 years before randomization.
Patients with an EDSS score of 0 to 6 inclusive at Screening. A score of 6.0 indicates unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting.
Patients treated with interferon beta or glatimer acetate can continue their treatment until randomization

Exclusion criteria

Patients with a history of malignancy of any organ system (other than cutaneous basal cell carcinoma)
Patients with an active chronic disease (or stable but treated with immune therapy) of the immune system other than MS (e.g., rheumatoid arthritis, scleroderma, Sjogren's syndrome, Crohn's disease, ulcerative colitis) or with a known immunodeficiency syndrome (HIV-antibody positive, AIDS, hereditary immune deficiency, drug-induced immune deficiency).
Patients who have been treated with:
High-dose intravenous (IV) immunoglobulin (Ig) within 2 months before randomization
Immunosuppressive/chemotherapeutic medications (e.g., azathioprine, cyclophosphamide, methotrexate) within 6 months before randomization
Monoclonal antibodies (including natalizumab) within 6 months before randomization
Rituximab, alemtuzumab, ofatumumab, ocrelizumab, mitoxantrone or cladribine at any time before randomization
Patients who have been treated with corticosteroids or adrenocorticotropic hormones in the past 30 days before the screening visit
Patients with uncontrolled diabetes mellitus (HbA1c >7%)
Patients with a diagnosis of macular edema during Screening (patients with a history of macular edema will be allowed to enter the study provided that they do not have macular edema at Screening)
Positive screening for serological markers for hepatitis A, B, C, and E indicating acute or chronic infection:
Patients who are negative for varicella zoster virus IgG antibodies at Screening
Patients who have received any live or live attenuated vaccines (including for varicella zoster virus, herpes simplex, or measles) within 1 month before randomization
Patients who have received total lymphoid irradiation or bone marrow transplantation
Patients with any unstable medical/psychiatric condition, as assessed by the primary treating physician at each site
Study Locations And Contact Information

Novartis Investigative Site, Round Rock Texas
Novartis Investigative Site, Akron Ohio
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Pompano Beach Florida
Novartis Investigative Site, Port Charlotte Florida
Novartis Investigative Site, Charlottesville Virginia
Novartis Investigative Site, Teaneck New Jersey
Novartis Investigative Site, Patchogue New York
Novartis Investigative Site, San Luis Potosi San Luis Potosí
Novartis Investigative Site, Fort Collins Colorado
Novartis Investigative Site, Oklahoma City Oklahoma
Novartis Investigative Site, Washington District of Columbia
Novartis Investigative Site, Providence Rhode Island
Novartis Investigative Site, New York New York
Novartis Investigative Site, Burnaby British Columbia
Novartis Investigative Site, Newark New Jersey
Novartis Investigative Site, Columbus Ohio
Novartis Investigative Site, Denver Colorado
Novartis Investigative Site, Amherst New York
Novartis Investigative Site, Edmonton Alberta
Novartis Investigative Site, Naples Florida
Novartis Investigative Site, Chihuahua
Novartis Investigative Site, Dayton Ohio
Novartis Investigative Site, Northbrook Illinois
Novartis Investigative Site, São Paulo SP
Novartis Investigative Site, Aguascalientes
Novartis Investigative Site, Sacramento California
Novartis Investigative Site, Guaynabo
Novartis Investigative Site, Campina Grande do Sul
Novartis Investigative Site, Newark Delaware
Novartis Investigative Site, Fairfield Connecticut
Novartis Investigative Site, Kansas City Missouri
Novartis Investigative Site, Chapel Hill North Carolina
Novartis Investigative Site, Rochester New York
Novartis Investigative Site, Jacksonville Florida
Novartis Investigative Site, Columbus Ohio
Novartis Investigative Site, Kansas City Missouri
Novartis Investigative Site, New Brunswick New Jersey
Novartis Investigative Site, Oklahoma City Oklahoma
Novartis Investigative Site, Ottawa Ontario
Novartis Investigative Site, Albany New York
Novartis Investigative Site, Aurora Colorado
Novartis Investigative Site, Tulsa Oklahoma
Novartis Investigative Site, New Orleans Louisiana
Novartis Investigative Site, Toledo Ohio
Novartis Investigative Site, Aguascalientes
Novartis Investigative Site, Sarasota Florida
Novartis Investigative Site, Los Angeles California
Novartis Investigative Site, Campina Grande do Sul
Novartis Investigative Site, New Brunswick New Jersey
Novartis Investigative Site, New Port Richey Florida
Novartis Investigative Site, Springfield Massachusetts
Novartis Investigative Site, Seattle Washington
Novartis Investigative Site, Elk Grove Village Illinois
Novartis Investigative Site, Saint Louis Missouri
Novartis Investigative Site, Detroit Michigan
Novartis Investigative Site, Novi Michigan
Novartis Investigative Site, Burnaby British Columbia
Novartis Investigative Site, Sarasota Florida
Novartis Investigative Site, Stony Brook New York
Novartis Investigative Site, Porto Alegre RS
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Ormond Beach Florida
Novartis Investigative Site, Louisville Kentucky
Novartis Investigative Site, St. Louis Missouri
Novartis Investigative Site, Syracuse New York
Novartis Investigative Site, Issaquah Washington
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Charlotte North Carolina
Novartis Investigative Site, Winston-Salem North Carolina
Novartis Investigative Site, Memphis Tennessee
Novartis Investigative Site, Altoona Pennsylvania
Novartis Investigative Site, Knoxville Tennessee
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Flossmoor Illinois
Novartis Investigative Site, Regina
Novartis Investigative Site, Saint Louis Missouri
Novartis Investigative Site, Mexico City
Novartis Investigative Site, West Palm Beach Florida
Novartis Investigative Site, La Jolla California
Novartis Investigative Site, Santiago
Novartis Investigative Site, Douglasville Georgia
Novartis Investigative Site, Montreal Quebec
Novartis Investigative Site, St. Louis Missouri
Novartis Investigative Site, Huntsville Alabama
Novartis Investigative Site, Detroit Michigan
Novartis Investigative Site, Seattle Washington
Novartis Investigative Site, Columbus Ohio
Novartis Investigative Site, Lexington Kentucky
Novartis Investigative Site, Albany New York
Novartis Investigative Site, Hammond Louisiana
Novartis Investigative Site, Traverse City Michigan
Novartis Investigative Site, Houston Texas
Novartis Investigative Site, Richmond Virginia
Novartis Investigative Site, Chihuahua
Novartis Investigative Site, Montreal Quebec
Novartis Investigative Site, Loveland Colorado
Novartis Investigative Site, Vero Beach Florida
Novartis Investigative Site, Sacramento California
Novartis Investigative Site, Tlalnepantla Mexico
Novartis Investigative Site, Atlanta Georgia
Novartis Investigative Site, Cleveland Ohio
Novartis Investigative Site, Quincy Massachusetts
Novartis Investigative Site, Naples Florida
Novartis Investigative Site, West Des Moines Iowa
Novartis Investigative Site, Grand Rapids Michigan
Novartis Investigative Site, Hershey Pennsylvania
Novartis Investigative Site, Phoenix Arizona
Novartis Investigative Site, New Orleans Louisiana
Novartis Investigative Site, Monterrey Nuevo
Novartis Investigative Site, Joinville SC
Novartis Investigative Site, Phoenix Arizona
Novartis Investigative Site, São Paulo SP
Novartis Investigative Site, Knoxville Tennessee
Novartis Investigative Site, Nashville Tennessee
Novartis Investigative Site, Milwaukee Wisconsin
Novartis Investigative Site, Santiago
Novartis Investigative Site, Sherman Texas
Novartis Investigative Site, Chihuahua
Novartis Investigative Site, Elk Grove Village Illinois
Novartis Investigative Site, Cullman Alabama
Novartis Investigative Site, Boston Massachusetts
Novartis Investigative Site, Colorado Springs Colorado
Novartis Investigative Site, Philadelphia Pennsylvania
Novartis Investigative Site, Las Vegas Nevada
Novartis Investigative Site, Seattle Washington
Novartis Investigative Site, Grand Rapids Michigan
Novartis Investigative Site, Winston-Salem North Carolina
Novartis Investigative Site, Nashville Tennessee
Novartis Investigative Site, Alexandria Virginia
Novartis Investigative Site, Tlalnepantla, Mexico
Novartis Investigative Site, Indianapolis Indiana
Novartis Investigative Site, Torrance California
Novartis Investigative Site, Issaquah Washington
Novartis Investigative Site, Sun City Arizona
Novartis Investigative Site, Kansas City Kansas
Novartis Investigative Site, Chicoutimi Quebec
Novartis Investigative Site, Roanoke Virginia
Novartis Investigative Site, Philadelphia Pennsylvania
Novartis Investigative Site, Salt Lake City Utah
Novartis Investigative Site, Jacksonville Florida
Novartis Investigative Site, Memphis Tennessee
Novartis Investigative Site, Rio Grande do Sul
Novartis Investigative Site, Montreal Quebec
Novartis Investigative Site, Newark New Jersey
Novartis Investigative Site, Detroit Michigan
Novartis Investigative Site, Great Falls Montana
Novartis Investigative Site, Providence Rhode Island
Novartis Investigative Site, Phoenix Arizona
Novartis Investigative Site, Salt Lake City Utah
Novartis Investigative Site, Baltimore Maryland
Novartis Investigative Site, Indianapolis Indiana
Novartis Investigative Site, Kingston Ontario
Novartis Investigative Site, Huntsville Alabama
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Philadelphia Pennsylvania
Novartis Investigative Site, Halifax Nova Scotia
Novartis Investigative Site, Houston Texas
Novartis Investigative Site, Passo Fundo
Novartis Investigative Site, Rio Grande do Sul
Novartis Investigative Site, Washington District of Columbia
Novartis Investigative Site, Aurora Colorado
Novartis Investigative Site, Fairfield Connecticut
Novartis Investigative Site, Norfolk Virginia
Novartis Investigative Site, Oklahoma City Oklahoma
Novartis Investigative Site, Evanston Illinois
Novartis Investigative Site, Belo Horizonte Minas Gerais
Novartis Investigative Site, Clinton Township Michigan
Novartis Investigative Site, Indianapolis Indiana
Novartis Investigative Site, Bellevue Ohio
Novartis Investigative Site, Santiago
Novartis Investigative Site, Buffalo New York
Novartis Investigative Site, Plainview New York
Novartis Investigative Site, Maitland Florida
Novartis Investigative Site, Chapel Hill North Carolina
Novartis Investigative Site, Columbus Ohio
Novartis Investigative Site, Plainview New York
Novartis Investigative Site, Guaynabo
Novartis Investigative Site, Sherman Texas
Novartis Investigative Site, Loveland Colorado
Novartis Investigative Site, Baltimore Maryland
Novartis Investigative Site, Great Falls Montana
Novartis Investigative Site, Passo Fundo
Novartis Investigative Site, Phoenix Arizona
Novartis Investigative Site, Tucson Arizona
Novartis Investigative Site, Hammond Louisiana
Novartis Investigative Site, Fort Collins Colorado
Novartis Investigative Site, New York New York
Novartis Investigative Site, Albuquerque New Mexico
Novartis Investigative Site, Hershey Pennsylvania
Novartis Investigative Site, Toledo Ohio
Novartis Investigative Site, Albuquerque New Mexico
Novartis Investigative Site, Atlanta Georgia
Novartis Investigative Site, Sarasota Florida
Novartis Investigative Site, Buenos aires
Novartis Investigative Site, Regina
Novartis Investigative Site, Torrance California
Novartis Investigative Site, Kansas City Kansas
Novartis Investigative Site, Ponte Vedra Beach Florida
Novartis Investigative Site, Freehold New Jersey
Novartis Investigative Site, Derby Connecticut
Novartis Investigative Site, Norfolk Virginia
Novartis Investigative Site, Evanston Illinois
Novartis Investigative Site, Newark Delaware
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Charlotte North Carolina
Novartis Investigative Site, Santiago
Novartis Investigative Site, Ottawa Ontario
Novartis Investigative Site, Pompano Beach Florida
Novartis Investigative Site, Oceanside California
Novartis Investigative Site, Buenos aires
Novartis Investigative Site, Hollywood Florida
Novartis Investigative Site, Albuquerque New Mexico
Novartis Investigative Site, Tampa Florida
Novartis Investigative Site, Lenexa Kansas
Novartis Investigative Site, Richmond Virginia
Novartis Investigative Site, Roanoke Virginia
Novartis Investigative Site, Boulder Colorado
Novartis Investigative Site, Orlando Florida
Novartis Investigative Site, St. Louis Missouri
Novartis Investigative Site, Dallas Texas
Novartis Investigative Site, Patchogue New York
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Porto Alegre RS
Novartis Investigative Site, Chihuahua
Novartis Investigative Site, Seattle Washington
Novartis Investigative Site, Spartanburg South Carolina
Novartis Investigative Site, Boston Massachusetts
Novartis Investigative Site, West Des Moines Iowa
Novartis Investigative Site, Detroit Michigan
Novartis Investigative Site, Mexico Distrito Federal
Novartis Investigative Site, San Antonio Texas
Novartis Investigative Site, Spartanburg South Carolina
Novartis Investigative Site, Sacramento California
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Great Falls Montana
Novartis Investigative Site, Flossmoor Illinois
Novartis Investigative Site, Albuquerque New Mexico
Novartis Investigative Site, Lexington Kentucky
Novartis Investigative Site, Tallahassee Florida
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Colorado Springs Colorado
Novartis Investigative Site, Ormond Beach Florida
Novartis Investigative Site, Dallas Texas
Novartis Investigative Site, Ponte Vedra Beach Florida
Novartis Investigative Site, Nashville Tennessee
Novartis Investigative Site, Portloand Oregon

www.MDLinx.com
_________________
Be Joyful, Heal Yourself and Age Gracefully!
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    masterhormones.com Forum Index -> US Healthcare rules and regulations All times are GMT - 8 Hours
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum


Powered by phpBB © 2001, 2002 phpBB Group

Template created by phpbb2.de

Entireweb Search Engine
Search

This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research ,educational and hormone testing purposes.If the master hormones deficiency is detected, the secondary prevention or integrative treatment would be necessary for healthy ageing . Please consult your endocrinologist for diagnosis and conventional treatment.
Web site engine code is Copyright © 2003 by PHP-Nuke.
Master Hormones News


Page Generation: 0.54 Seconds

E-Gurzuf Holding Co.
Masterhormones.com 2006